University of Michigan Health’s adult hospitals were ranked best in Michigan and 17th in the nation by U.S. News & World Report “Best Hospitals” rankings for 2022-2023. This prestigious honor measures excellence in patient care.

Three oases at the hospital offer respite for health care providers

The findings highlight the importance of regular monitoring of thyroid function and prompt correction of over- and under-treatment with thyroid hormone to reduce patient harm.

During the lengthy hospital stays that Ann Laho’s daughter endured, one nurse’s compassion inspired the mother-daughter pair to pursue the profession and help patients the same way she helped their family.

Michigan Medicine received an ‘A’ Leapfrog Hospital Safety Grade for spring 2022. This distinction recognizes Michigan Medicine’s achievements in protecting patients from preventable harm and error in the hospital.

A new mother with quadriplegia reflects on what she thought was an impossible dream of growing her family.

Age-related macular degeneration (AMD) is the leading cause of irreversible blindness in people over 50. An $11.5 million gift to the University of Michigan Health W.K. Kellogg Eye Center aims to change that.

The largest study to investigate the role of inflammatory biomarkers in hospitalized COVID-19 patients uncovers risk factors for worse health outcomes in those with diabetes.

How the Detroit Zoo and doctors helped a chimpanzee rejoin his community.

The anti-cancer effect of the drug may help those with rare, hereditary cancer syndromes avoid surgeries by shrinking tumors via a daily oral dose.

In type 1 diabetes, new research identifies critical ways to improve blood sugar management across different demographic groups.

An endocrinologist discusses the history of the life-saving drug and its importance in diabetes management.

Research finds COVID-19 associated with mental health problems after discharge, with majority not recognizing significant symptoms as a concern.

For adults with type 2 diabetes, pairing basal insulin with continuous glucose monitoring improved blood sugar and quality of life.

A novel therapeutic may halt rapid kidney function in some type 1 diabetic kidney disease patients.